A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
2020 · Nature · 4,813 citations
https://doi.org/10.1038/s41586-020-2286-9
V
Veronica V. Rezelj
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
41
Papers
8.5K
Citations
21
h-index
24
i10-index
Veronica V. Rezelj is an academic researcher from Human Vaccines Project Europe. The author has contributed to research in topics: Viral Infections and Vectors & SARS-CoV-2 and COVID-19 Research & Mosquito-borne diseases and control. The author has an h-index of 21, co-authored 35 publications.
ORCID: 0000-0003-1571-8325Papers by this author
worksDefective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts
2021 · Nature Communications · 67 citations
https://doi.org/10.1038/s41467-021-22341-7
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets
2023 · Nature Communications · 56 citations
https://doi.org/10.1038/s41467-023-41442-z
A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach
2023 · Scientific Reports · 6 citations
https://doi.org/10.1038/s41598-023-39662-w
Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial
2025 · Human Vaccines & Immunotherapeutics · 2 citations
https://doi.org/10.1080/21645515.2025.2450120
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat